Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Catalano · SciRah

Researcher profile · Semantic Scholar

L. Catalano

Share profile

L. Catalano — researcher profile on SciRah

h-index: 30
Works: 174
Citations: 5,155

Most-cited papers

Autologous transplantation and maintenance therapy in multiple myeloma.
A. Palumbo, F. Cavallo, F. Gay, F. Di Raimondo +23 more
2014New England Journal of Medicine746 citations Open access
Semantic Scholar
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
F. Gay, S. Oliva, M. Petrucci, C. Conticello +22 more
2015The Lancet Oncology312 citations Open access
Semantic Scholar
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
A. Larocca, F. Cavallo, S. Bringhen, F. Di Raimondo +21 more
2012Blood279 citations
Semantic Scholar
Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma
R. Fonti, M. Larobina, S. Del Vecchio, Serena de Luca +5 more
2012Journal of Nuclear Medicine185 citations Open access
Semantic Scholar
Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
Federica Cavallo, S. Bringhen, G. Milone, D. Ben-Yehuda +20 more
2011Leukemia60 citations Open access
Semantic Scholar
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis
F. Gay, S. Oliva, M. Petrucci, V. Montefusco +23 more
2017Leukemia45 citations Open access
Semantic Scholar
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.
P. Tacchetti, L. Pantani, F. Patriarca, M. Petrucci +93 more
2020The Lancet Haematology44 citations
Semantic Scholar
Longitudinal strain of left ventricular basal segments and E/e′ ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study
V. Schiano-Lomoriello, M. Galderisi, D. Mele, R. Esposito +7 more
2016Echocardiography36 citations
Semantic Scholar
A Phase III Study Of ASCT Vs Cyclophosphamide-Lenalidomide-Dexamethasone and Lenalidomide-Prednisone Maintenance Vs Lenalidomide Alone In Newly Diagnosed Myeloma Patients
A. Palumbo, A. Spencer, F. Di Raimondo, Adam Zdeněk +20 more
201333 citations
Semantic Scholar
18F-FDG PET/CT, 99mTc-MIBI, and MRI in the Prediction of Outcome of Patients With Multiple Myeloma: A Comparative Study
R. Fonti, L. Pace, C. Cerchione, L. Catalano +5 more
2015Clinical Nuclear Medicine32 citations
Semantic Scholar
Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study
A. Palumbo, F. Cavallo, I. Hardan, B. Lupo +26 more
201129 citations
Semantic Scholar
Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation
A. Brioli, G. Perrone, F. Patriarca, A. Pezzi +17 more
2015Bone Marrow Transplantation28 citations
Semantic Scholar
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma
R. Fonti, Sara Pellegrino, L. Catalano, F. Pane +2 more
2019Annals of Hematology26 citations
Semantic Scholar
Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience
C. Cerchione, A. de Renzo, M. Di Perna, R. Della Pepa +4 more
2016Supportive Care in Cancer24 citations Open access
Semantic Scholar
MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients
A. Rocci, M. Gambella, S. Aschero, I. Baldi +19 more
2014British Journal of Haematology24 citations Open access
Semantic Scholar
Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature
V. D. Di Crescenzo, A. Garzi, F. Petruzziello, M. Cinelli +3 more
2013BMC Surgery24 citations Open access
Semantic Scholar
Cytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myeloma
F. Petruzziello, P. Zeppa, G. Ciancia, I. Cozzolino +12 more
2011Leukemia and Lymphoma24 citations
Semantic Scholar
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case‐matched study
F. Morabito, S. Bringhen, A. Larocca, P. Wijermans +30 more
2014American journal of hematology/oncology23 citations Open access
Semantic Scholar
Maintenance Therapy With Lenalidomide Significantly Improved Survival Of Yong Newly Diagnosed Multiple Myeloma Patients
F. Cavallo, T. Caravita, Maide Cavalli, A. Nagler +20 more
201323 citations
Semantic Scholar
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series
E. Cantone, A. D. di Lullo, Luana Marano, E. Guadagno +4 more
2017Journal of Medical Case Reports21 citations Open access
Semantic Scholar
KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life: a retrospective survey in 123 patients
S. Palmieri, S. Rocco, O. Vitagliano, L. Catalano +16 more
2020Annals of Hematology17 citations
Semantic Scholar
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience
R. Iula, D. De Novellis, F. Trastulli, R. Della Pepa +20 more
2022Frontiers in Oncology16 citations Open access
Semantic Scholar
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials
E. Martino, C. Conticello, E. Zamagni, V. Pavone +29 more
2022Hematological Oncology15 citations
Semantic Scholar
Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience
C. Cerchione, L. Catalano, A. E. Pareto, M. Picardi +1 more
2015Supportive Care in Cancer14 citations
Semantic Scholar
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials.
M. D'Agostino, L. De Paoli, C. Conticello, M. Offidani +21 more
2018Critical reviews in oncology/hematology13 citations Open access
Semantic Scholar
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone
C. Cerchione, L. Catalano, I. Peluso, D. Nappi +5 more
2016Supportive Care in Cancer13 citations Open access
Semantic Scholar
Role of lenalidomide in the management of myelodysplastic syndromes with del(5q) associated with pure red cell aplasia (PRCA)
C. Cerchione, L. Catalano, G. Cerciello, S. Avilia +5 more
2015Annals of Hematology12 citations
Semantic Scholar
Second Primary Malignancies in Newly Diagnosed Multiple Myeloma Patients Treated with Lenalidomide: Analysis of Pooled Data in 2459 Patients
A. Palumbo, A. Larocca, S. Zweegman, Giulia Lupparelli +20 more
201112 citations
Semantic Scholar
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients
F. Morabito, E. Zamagni, C. Conticello, V. Pavone +40 more
2021European Journal of Haematology11 citations Open access
Semantic Scholar
Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support
C. Cerchione, A. de Renzo, D. Nappi, M. Di Perna +5 more
2019Supportive Care in Cancer10 citations
Semantic Scholar
Isolated unilateral absence of pulmonary artery mimicking chronic pulmonary embolism at chest X-ray: multidetector-row CT angiographic findings.
L. Camera, M. Fusari, M. Calabrese, C. Sirignano +4 more
2012Clinical imaging9 citations
Semantic Scholar
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials
F. Morabito, E. Zamagni, C. Conticello, V. Pavone +44 more
2022Frontiers in Oncology8 citations Open access
Semantic Scholar
Prognostic Impact of Cytogenetic Abnormalities On Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated with Thalidomide-Dexamethasone Incorporated Into Double Autologous Stem-Cell Transplantation: An Analysis of 593 Patients
E. Zamagni, N. Testoni, C. Terragna, P. Tacchetti +27 more
20108 citations
Semantic Scholar
Autologous Transplantation Versus Cyclophosphamide-Lenalidomide-Prednisone Followed By Lenalidomide-Prednisone Versus Lenalidomide Maintenance in Multiple Myeloma: Long-Term Results of a Phase III Trial
V. Magarotto, M. Petrucci, F. Di Raimondo, L. Pour +20 more
20156 citations
Semantic Scholar
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)
P. Musto, V. Simeon, N. Cascavilla, A. Falcone +24 more
2018Annals of Hematology5 citations
Semantic Scholar
Impact of Autologous Transplantation Vs. Chemotherapy Plus Lenalidomide in Newly Diagnosed Myeloma According to Patient Prognosis: Results of a Pooled Analysis of 2 Phase III Trials
C. Cerrato, R. Hájek, F. Di Raimondo, T. Caravita +21 more
20145 citations
Semantic Scholar
Combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy.
C. Cerchione, G. Martinelli, L. Catalano, N. Pugliese +5 more
2019Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Salvage therapy with pegylated liposomial doxorubicin‐based regimen in relapsed/refractory multiple myeloma: comments to the article by Romano et al.
C. Cerchione, Mariano Lucignano, F. Pane, L. Catalano
2016European Journal of Haematology4 citations
Semantic Scholar
Bortezomib (BOR)-Thalidomide-Dexamethasone (VTD) and High-Dose Melphalan (HDM) As First Line Treatment for Multiple Myeloma (MM) Is Associated with a Lower Rate of Second Primary Malignancies (SPMs) Compared to TD Plus HDM
A. Brioli, A. Pezzi, D. Derudas, M. Petti +14 more
20144 citations
Semantic Scholar
Safety and comfort of domestic bortezomib injection in real-life experience
C. Cerchione, D. Nappi, A. E. Pareto, M. Di Perna +4 more
2018Supportive Care in Cancer3 citations
Semantic Scholar
Cyberknife® system: a new therapeutic strategy for sinonasal solitary extramedullary plasmacytomae.
E. Cantone, V. Borzillo, A. D. di Lullo, Luana Marano +7 more
2017Journal of Biological Regulators and Homeostatic Agents3 citations
Semantic Scholar
P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
R. Iula, F. Trastulli, R. Della Pepa, A. D’Ambrosio +8 more
2022HemaSphere2 citations Open access
Semantic Scholar
Abstract
Sabrina Browning, L. Crawford, Terri L. Parker, Noffar Bar +9 more
2020American journal of hematology/oncology2 citations Open access
Semantic Scholar
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia
C. Cerchione, G. Martinelli, Silvana Pedatella, M. De Nisco +16 more
2019Anti-Cancer Drugs2 citations Open access
Semantic Scholar
Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease.
C. Cerchione, G. Cerciello, S. Avilia, R. Della Pepa +4 more
2018Blood transfusion = Trasfusione del sangue2 citations
Semantic Scholar
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide
C. Cerchione, D. Nappi, M. Di Perna, I. Zacheo +5 more
2017Clinical Case Reports2 citations Open access
Semantic Scholar
Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma
C. Cerchione, D. Nappi, M. Di Perna, I. Zacheo +4 more
2016Case Reports in Hematology2 citations Open access
Semantic Scholar
Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients.
P. Musto, V. Fraticelli, G. Mansueto, G. D'Arena +28 more
20122 citations
Semantic Scholar
MM-499 Pegfilgrastim Versus Filgrastim in the Supportive Care of Heavily Pretreated Multiple Myeloma in Treatment With Pomalidomide-Dexamethasone.
C. Cerchione, L. Catalano, D. Nappi, S. Ronconi +6 more
2022Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Addition of carfilzomib as a third agent in lenalidomide-refractory multiple myeloma: Switching from doublet to triplet.
C. Cerchione, D. Nappi, L. Catalano, S. Ronconi +4 more
2022Journal of Clinical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Pane×20
Invite
F. Pane — researcher profile on SciRah
M. Boccadoro×18
Invite
M. Boccadoro — researcher profile on SciRah
A. Palumbo×15
Invite
A. Palumbo — researcher profile on SciRah
F. Patriarca×14
Invite
F. Patriarca — researcher profile on SciRah

×13

Invite

F. Di Raimondo — researcher profile on SciRah

M. Petrucci×13

Invite

M. Petrucci — researcher profile on SciRah

Invite

P. Musto — researcher profile on SciRah

C. Cerchione×13

Invite

C. Cerchione — researcher profile on SciRah

M. Offidani×11

Invite

M. Offidani — researcher profile on SciRah

Invite

M. Picardi — researcher profile on SciRah

Invite

M. Cavo — researcher profile on SciRah

Invite

R. Ria — researcher profile on SciRah